Summary
The Institute of Molecular and Clinical Ophthalmology Basel (IOB) works with researchers and clinicians to advance the understanding of vision, its diseases and develop new therapies for vision loss 'these are its organisational objectives.
In May 2021, Nature Medicine published research on partial recovery of visual function in a blind patient after optogenetic therapy co-led by IOB Director Prof. Botond Roska. This journal publishes peer-reviewed research. Articles are open- access and can be viewed both by subscribers and the public. The site is visited by >38m scientists, healthcare professionals and science enthusiasts monthly.
The challenge was to...